Umbilical Cord Blood Transplantation Outcomes in Acute Myelogenous Leukemia/Myelodysplastic Syndrome Patients Aged ≥70 Years

Item

http://www.wikidata.org/entity/Q36623075

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Umbilical Cord Blood Transplan ...... ndrome Patients Aged ≥70 Years

@ast

Umbilical Cord Blood Transplan ...... ndrome Patients Aged ≥70 Years

@en

type

Item

label

Umbilical Cord Blood Transplan ...... ndrome Patients Aged ≥70 Years

@ast

Umbilical Cord Blood Transplan ...... ndrome Patients Aged ≥70 Years

@en

prefLabel

Umbilical Cord Blood Transplan ...... ndrome Patients Aged ≥70 Years

@ast

Umbilical Cord Blood Transplan ...... ndrome Patients Aged ≥70 Years

@en

P1476

Umbilical Cord Blood Transplan ...... ndrome Patients Aged ≥70 Years

@en

P2093

Celalettin Ustun

http://www.w3.org/2001/XMLSchema#string

Claudio Brunstein

http://www.w3.org/2001/XMLSchema#string

Daniel Weisdorf

http://www.w3.org/2001/XMLSchema#string

Erica Warlick

http://www.w3.org/2001/XMLSchema#string

Karamjeet S Sandhu

http://www.w3.org/2001/XMLSchema#string

Mukta Arora

http://www.w3.org/2001/XMLSchema#string

Nelli Bejanyan

http://www.w3.org/2001/XMLSchema#string

Todd DeFor

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome.

Alternative donor transplantation for older patients with acute myeloid leukemia in first complete remission: a center for international blood and marrow transplant research-eurocord analysis.

Reduced-intensity hematopoietic cell transplantation in older patients with AML/MDS: umbilical cord blood is a feasible option for patients without HLA-matched sibling donors

Comparison of allogeneic hematopoietic cell transplantation and chemotherapy in elderly patients with non-M3 acute myelogenous leukemia in first complete remission.

Comparison of reduced-intensity hematopoietic cell transplantation with chemotherapy in patients age 60-70 years with acute myelogenous leukemia in first remission.

Revised international prognostic scoring system for myelodysplastic syndromes.

Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation.

Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease.

Immune recovery in adult patients after myeloablative dual umbilical cord blood, matched sibling, and matched unrelated donor hematopoietic cell transplantation.

Prognostic significance of the European LeukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia.

P304

390-393

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBMT.2015.09.020

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282344527

http://www.w3.org/2001/XMLSchema#string

P698

26415559

http://www.w3.org/2001/XMLSchema#string

P932

4768714

http://www.w3.org/2001/XMLSchema#string